Guest guest Posted July 8, 2011 Report Share Posted July 8, 2011 Contributed by Dr Nadini Kumar Vijay -------------------------------- Research & Event Grant Proposals Due Wednesday, September 19, 2011 DIA serves nearly 30,000 professionals in the biotechnology, pharmaceutical, health sciences and regulatory industries worldwide. Through international meetings, training courses, publications and other offerings, DIA provides a neutral global forum for the exchange of information critical to advancing the drug discovery and life-cycle management processes. Seeking Research and Event Grant Proposals DIA is accepting applications for research grants and event grants through the DIA Philanthropy Program, the means by which DIA supports charitable causes that benefit the public and help fulfill the association's mission, vision and social responsibility. Charitable causes include education through the exchange of information and ideas for the improvement of society through greater access to, and the proper and appropriate usage of, pharmaceutical, biotechnology, medical devices, vaccines, combination products, and related health care products. DIA's educational efforts also encompass better understanding of the health and economic benefits of such products through development and research. For this year, the DIA will focus on charitable organizations that support the following: Increase the knowledge and understanding of patient groups, government, and industry about key issues central to the promotion of patient-centered health care Develop the capacity of patient groups to lead and facilitate for change Improve alliances between patient groups and other health care stakeholders Research and event grant proposals due Monday September 19, 2011. Please direct any inquiries on these subjects to philanthropy@... Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.